Nursing Elites

1. What type of medication is used to relax the muscles around the airways and improve breathing in conditions like asthma and COPD?

• A. Bronchodilator
• B. Corticosteroid
• C. Mucolytic
• D. Antihistamine

Correct answer: A

Rationale: Bronchodilators are medications that relax the muscles around the airways, improving airflow and making breathing easier for patients with asthma or COPD. Corticosteroids are anti-inflammatory drugs used to reduce airway inflammation, while mucolytics help in thinning and clearing mucus. Antihistamines are used to treat allergies and not specifically to improve breathing in conditions like asthma or COPD.

2. What is the term for the amount of blood ejected by the left ventricle into the aorta per beat, determined by preload, contractility, and afterload?

• A. Stroke volume
• B. Cardiac output
• C. End-diastolic volume
• D. Ejection fraction

Correct answer: A

Rationale: The correct answer is A: Stroke volume. Stroke volume refers to the volume of blood ejected by the left ventricle during each heartbeat. This is determined by preload (the degree of stretch of the cardiac muscle fibers at the end of diastole), contractility (the force of myocardial contraction), and afterload (the pressure or resistance that the ventricle must overcome to eject blood). Choice B, Cardiac output, is the volume of blood pumped by the heart per minute and is calculated by multiplying the heart rate by the stroke volume. Choice C, End-diastolic volume, is the volume of blood in the ventricle at the end of diastole before contraction. Choice D, Ejection fraction, is the proportion of blood pumped out of the ventricle with each contraction, calculated by dividing the stroke volume by the end-diastolic volume.

3. Which of the following is a type of heart valve disease where the aortic valve becomes narrowed, restricting blood flow from the heart to the rest of the body?

• A. Aortic stenosis
• B. Mitral stenosis
• C. Tricuspid regurgitation
• D. Pulmonary hypertension

Correct answer: A

Rationale: The correct answer is Aortic stenosis. In aortic stenosis, the aortic valve becomes narrowed, which obstructs the blood flow from the heart to the rest of the body. This condition can lead to symptoms like chest pain, shortness of breath, and fainting. Mitral stenosis (choice B) involves narrowing of the mitral valve, not the aortic valve. Tricuspid regurgitation (choice C) is a condition where the tricuspid valve leaks, causing blood to flow backward in the heart. Pulmonary hypertension (choice D) is high blood pressure in the arteries of the lungs.

4. What condition is characterized by the inflammation of the pleura, causing sharp chest pain that worsens with breathing?

• A. Pleurisy
• B. Pericarditis
• C. Endocarditis
• D. Myocarditis

Correct answer: A

Rationale: The correct answer is Pleurisy. Pleurisy is the inflammation of the pleura, the lining surrounding the lungs, which causes sharp chest pain that worsens with breathing. Pericarditis (choice B) is the inflammation of the pericardium, the sac around the heart, which typically causes chest pain that worsens when lying down. Endocarditis (choice C) is the inflammation of the inner lining of the heart chambers and valves, leading to symptoms like fever, fatigue, and abnormal heart sounds. Myocarditis (choice D) is inflammation of the heart muscle, which can cause symptoms such as chest pain, fatigue, and shortness of breath.

5. The client on spironolactone (Aldactone) has a potassium level of 5.6 mEq/L. What is the nurse’s priority action?

• A. Hold the spironolactone and notify the healthcare provider.
• B. Administer potassium supplements.
• C. Continue the spironolactone as ordered.
• D. Increase the dose of spironolactone.

Correct answer: A

Rationale: The correct answer is A: Hold the spironolactone and notify the healthcare provider. A potassium level of 5.6 mEq/L is high, indicating hyperkalemia. Spironolactone is a potassium-sparing diuretic that can further elevate potassium levels. Therefore, the priority action is to withhold the medication to prevent exacerbating hyperkalemia and notify the healthcare provider for further management. Option B is incorrect because administering potassium supplements would worsen the hyperkalemia. Option C is incorrect as continuing spironolactone can lead to a further increase in potassium levels. Option D is incorrect as increasing the dose of spironolactone would be inappropriate in the presence of elevated potassium levels.

Similar Questions